6qc-ICG

SPRAYDYE-Trial - A phase I/II study to assess the efficacy, safety and tolerability of topically applied 6qc-ICG, a cathepsin-activatable fluorescent probe, for real-time intraoperative resection margin assessment in breast conserving surgery

Study on the effect of 6qc-ICG on the skin of healthy volunteers and in patients with breast cancer during surgeries.